Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Jankovic

Showing results (21-30 of 670) with videos related to

Pageof 67
Sort By:
Pain|August 18, 2017
Statin-related musculoskeletal pain in Parkinson's diseaseJoseph Jankovic
Toxicon : Official Journal of the International Society on Toxinology|September 11, 2017
An update on new and unique uses of botulinum toxin in movement disordersJoseph Jankovic
The Lancet. Neurology|December 21, 2007
Parkinson's disease and movement disorders: moving forwardJoseph Jankovic
Nature Reviews. Neurology|January 14, 2017
Movement disorders in 2016: Progress in Parkinson disease and other movement disordersJoseph Jankovic
Annals of Neurology|April 3, 2008
Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?Joseph Jankovic
Neurologic Clinics|April 4, 2025
Parkinson DiseaseJoseph Jankovic
The Lancet. Neurology|August 15, 2009
Treatment of hyperkinetic movement disordersJoseph Jankovic
Nature Reviews. Neurology|September 30, 2017
Parkinson disease: Exenatide - a drug for diabetes and Parkinson disease?Joseph Jankovic
Journal of the Neurological Sciences|April 14, 2009
Atomoxetine for freezing of gait in Parkinson diseaseJoseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2018
Pathogenesis-targeted therapeutic strategies in Parkinson's diseaseJoseph Jankovic
Pageof 67

Showing results (21-30 of 670) with videos related to

Sort By:
Pageof 67
Pain|August 18, 2017
Statin-related musculoskeletal pain in Parkinson's diseaseJoseph Jankovic
Toxicon : Official Journal of the International Society on Toxinology|September 11, 2017
An update on new and unique uses of botulinum toxin in movement disordersJoseph Jankovic
The Lancet. Neurology|December 21, 2007
Parkinson's disease and movement disorders: moving forwardJoseph Jankovic
Nature Reviews. Neurology|January 14, 2017
Movement disorders in 2016: Progress in Parkinson disease and other movement disordersJoseph Jankovic
Annals of Neurology|April 3, 2008
Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?Joseph Jankovic
Neurologic Clinics|April 4, 2025
Parkinson DiseaseJoseph Jankovic
The Lancet. Neurology|August 15, 2009
Treatment of hyperkinetic movement disordersJoseph Jankovic
Nature Reviews. Neurology|September 30, 2017
Parkinson disease: Exenatide - a drug for diabetes and Parkinson disease?Joseph Jankovic
Journal of the Neurological Sciences|April 14, 2009
Atomoxetine for freezing of gait in Parkinson diseaseJoseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2018
Pathogenesis-targeted therapeutic strategies in Parkinson's diseaseJoseph Jankovic
Pageof 67